Literature DB >> 6315666

Isolation and characterization of ancovenin, a new inhibitor of angiotensin I converting enzyme, produced by actinomycetes.

Y Kido, T Hamakado, T Yoshida, M Anno, Y Motoki, T Wakamiya, T Shiba.   

Abstract

Ancovenin, an inhibitor of angiotensin I converting enzyme isolated from the culture broth of a Streptomyces species, is a dialysable peptide composed of sixteen amino acid residues containing unusual amino acids such as threo-beta-methyllanthionine, meso-lanthionine, and dehydroalanine.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6315666     DOI： 10.7164/antibiotics.36.1295

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  11 in total

1.  Comparative studies on the fermentative production of lantibiotics by staphylococci.

Authors:  T Hörner; V Ungermann; H Zähner; H P Fiedler; R Utz; R Kellner; G Jung
Journal:  Appl Microbiol Biotechnol       Date:  1990-02       Impact factor: 4.813

2.  O-Methyltransferase-Mediated Incorporation of a β-Amino Acid in Lanthipeptides.

Authors:  Jeella Z Acedo; Ian R Bothwell; Linna An; Abby Trouth; Clara Frazier; Wilfred A van der Donk
Journal:  J Am Chem Soc       Date:  2019-10-15       Impact factor: 15.419

3.  Transcription analysis of a lantibiotic gene cluster from Bifidobacterium longum DJO10A.

Authors:  Ju-Hoon Lee; Xiulan Li; Daniel J O'Sullivan
Journal:  Appl Environ Microbiol       Date:  2011-07-08       Impact factor: 4.792

4.  Assessing the Flexibility of the Prochlorosin 2.8 Scaffold for Bioengineering Applications.

Authors:  Julian D Hegemann; Silvia C Bobeica; Mark C Walker; Ian R Bothwell; Wilfred A van der Donk
Journal:  ACS Synth Biol       Date:  2019-05-08       Impact factor: 5.110

5.  Isolation and structure determination of a new lantibiotic cinnamycin B from Actinomadura atramentaria based on genome mining.

Authors:  Shinya Kodani; Hisayuki Komaki; Sho Ishimura; Hikaru Hemmi; Mayumi Ohnishi-Kameyama
Journal:  J Ind Microbiol Biotechnol       Date:  2016-06-02       Impact factor: 3.346

Review 6.  Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings.

Authors:  Anton Du Preez van Staden; Winschau F van Zyl; Marla Trindade; Leon M T Dicks; Carine Smith
Journal:  Appl Environ Microbiol       Date:  2021-06-25       Impact factor: 4.792

7.  In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria.

Authors:  Alan J Marsh; Orla O'Sullivan; R Paul Ross; Paul D Cotter; Colin Hill
Journal:  BMC Genomics       Date:  2010-11-30       Impact factor: 3.969

8.  Structural characterization of four prochlorosins: a novel class of lantipeptides produced by planktonic marine cyanobacteria.

Authors:  Weixin Tang; Wilfred A van der Donk
Journal:  Biochemistry       Date:  2012-05-17       Impact factor: 3.162

9.  Production of Antihypertensive Angiotensin I-Converting Enzyme Inhibitor from Malassezia pachydermatis G-14.

Authors:  Seung Chan Jeong; Jae Ho Kim; Na-Mi Kim; Jong Soo Lee
Journal:  Mycobiology       Date:  2005-09-30       Impact factor: 1.858

Review 10.  Probiotics at War Against Viruses: What Is Missing From the Picture?

Authors:  Santosh Kumar Tiwari; Leon M T Dicks; Igor V Popov; Alena Karaseva; Alexey M Ermakov; Alexander Suvorov; John R Tagg; Richard Weeks; Michael L Chikindas
Journal:  Front Microbiol       Date:  2020-08-20       Impact factor: 6.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.